Search Results - "SEREMET, Teofila"

A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastases by Jansen, Yanina, Kruse, Vibeke, Corthals, Jurgen, Schats, Kelly, van Dam, Pieter-Jan, Seremet, Teofila, Heirman, Carlo, Brochez, Lieve, Kockx, Mark, Thielemans, Kris, Neyns, Bart

“…Background Autologous monocyte-derived mRNA co-electroporated dendritic cells with mRNA encoding CD40 ligand (CD40L), CD70 and a constitutively activated TLR4…”
Get full text

Undetectable circulating tumor DNA (ctDNA) levels correlate with favorable outcome in metastatic melanoma patients treated with anti-PD1 therapy by Seremet, Teofila, Jansen, Yanina, Planken, Simon, Njimi, Hassan, Delaunoy, Mélanie, El Housni, Hakim, Awada, Gil, Schwarze, Julia Katharina, Keyaerts, Marleen, Everaert, Hendrik, Lienard, Danielle, Del Marmol, Véronique, Heimann, Pierre, Neyns, Bart

“…Treatment with anti-PD1 monoclonal antibodies improves the survival of metastatic melanoma patients but only a subgroup of patients benefits from durable…”
Get full text

Neogenesis of Lymphoid Structures and Antibody Responses Occur in Human Melanoma Metastases by CIPPONI, Arcadi, MERCIER, Marjorie, SEREMET, Teofila, BAURAIN, Jean-François, THEATE, Ivan, VAN DEN OORD, Joost, STAS, Marguerite, BOON, Thierry, COULIE, Pierre G, VAN BAREN, Nicolas

“…Lymphoid neogenesis, or the development of lymphoid structures in nonlymphoid organs, is frequently observed in chronically inflamed tissues, during the course…”
Get full text

Pembrolizumab for the treatment of uveal melanoma: A case series by Jansen, Yanina Jeanne Leona, Seremet, Teofila, Neyns, Bart

“…Uveal melanoma is a rare disease. Up to 50% of the patients will develop metastases for which the treatment options are limited. No randomized controlled data…”
Get full text

Diagnosis and management of COVID toes in outpatients: a case report by Pouxe, Marie, Abdulkarim, Aziz, de Vallière, Serge, Seremet, Teofila, Favrat, Bernard, Kokkinakis, Ioannis

“…Since the beginning of the coronavirus disease 2019 pandemic, the most common skin lesions observed due to infection with the severe acute respiratory syndrome…”
Get full text

Long-term disease control of Langerhans cell histiocytosis using combined BRAF and MEK inhibition by Awada, Gil, Seremet, Teofila, Fostier, Karel, Everaert, Hendrik, Neyns, Bart

“…•Treatment with a BRAF and MEK inhibitor can achieve a sustained response in BRAFV600-mutant Langerhans cell histiocytosis.•Detection of plasma BRAFV600-mutant…”
Get full text

Combination of dabrafenib plus trametinib for BRAF and MEK inhibitor pretreated patients with advanced BRAFV600 -mutant melanoma: an open-label, single arm, dual-centre, phase 2 clinical trial by Schreuer, Max, MD, Jansen, Yanina, MD, Planken, Simon, MB, Chevolet, Ines, PhD, Seremet, Teofila, MD, Kruse, Vibeke, PhD, Neyns, Bart, Dr

“…Summary Background Patients with BRAFV600 -mutant melanoma benefit from treatment with the combination of BRAF and MEK inhibitors, but resistance and disease…”
Get full text

Objective responses can be obtained by CTLA-4 inhibition in metastatic melanoma after BRAF inhibitor failure by Schreuer, Max S, Chevolet, Ines L, Jansen, Yanina J, Seremet, Teofila C, Wilgenhof, Sofie, Liénard, Danielle, Del Marmol, Veronique, Neyns, Bart

“…The aim of this study was to determine the activity of ipilimumab (ipi)-based therapy after treatment failure with a BRAF inhibitor (BRAFi). Sixty-four…”
Get full text

A Case Report of Long-Term Survival following Hepatic Arterial Infusion of L-Folinic Acid Modulated 5-Fluorouracil Combined with Intravenous Irinotecan and Cetuximab Followed by Hepatectomy in a Patient with Initially Unresectable Colorectal Liver Metastases by Delvaux, Georges, Engels, Benedikt, Seremet, Teofila, Jansen, Yanina, Van Bael, Kobe, Neyns, Bart

“…A 43-year-old women admitted to our hospital for weight loss, anorexia, and abdominal pain was diagnosed with sigmoid neoplasm and multiple bilobar liver…”
Get full text

Single-centre experience with tralokinumab in dupilumab-experienced and naïve patients with atopic dermatitis by Fossati, Claire, Guenova, Emmanuella, Conrad, Curdin, Gilliet, Michel, Seremet, Teofila

Get full text

Phase 2 Trial of Nivolumab Combined With Stereotactic Body Radiation Therapy in Patients With Metastatic or Locally Advanced Inoperable Melanoma by Sundahl, Nora, Seremet, Teofila, Van Dorpe, Jo, Neyns, Bart, Ferdinande, Liesbeth, Meireson, Annabel, Brochez, Lieve, Kruse, Vibeke, Ost, Piet

“…Nivolumab improves survival in patients with metastatic melanoma. Unfortunately, most patients do not respond to this treatment. Preclinical data indicate that…”
Get full text

Allergic contact dermatitis from pentylene glycol in ‘hypoallergenic’ eye cosmetics by Seremet, Teofila, Aerts, Olivier, Walker, Anna, Wüthrich, Héloïse, Dendooven, Ella, Goossens, An, Gilliet, Michel

Get full text

Allergic contact dermatitis from pantolactone and dexpanthenol in wound healing creams by Blanchard, Gabriela, Kerre, Stefan, Walker, Anna, Dendooven, Ella, Aerts, Olivier, Goossens, An, Gilliet, Michel, Seremet, Teofila

Get full text

Allergic contact dermatitis from a skin‐calming cream containing hydroxyphenyl propamidobenzoic acid by Blanchard, Gabriela, Walker, Anna, Dendooven, Ella, Aerts, Olivier, Goossens, An, Gilliet, Michel, Seremet, Teofila

Get full text

Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with BRAF/MEK inhibitors by Schreuer, Max, Meersseman, Geert, Van Den Herrewegen, Sari, Jansen, Yanina, Chevolet, Ines, Bott, Ambre, Wilgenhof, Sofie, Seremet, Teofila, Jacobs, Bart, Buyl, Ronald, Maertens, Geert, Neyns, Bart

“…BRAF V600 mutant circulating cell-free tumor DNA (BRAF V600mut ctDNA) could serve as a specific biomarker in patients with BRAF V600 mutant melanoma. We…”
Get full text

A sequential dual cohort phase II clinical trial on adjuvant low-dose nivolumab with or without low-dose ipilimumab as adjuvant therapy following the resection of melanoma macrometastases (MM) by Schwarze, Julia Katharina, Vandersleyen, Valerie, Awada, Gil, Jansen, Yanina, Seremet, Teofila, Neyns, Bart

“…Abstract only 9585 Background: Optimal dosing and duration of adjuvant treatment with anti-PD-1 checkpoint inhibitors, e.g. nivolumab (NIVO), following…”
Get full text

It is not always chlorhexidine: Identification of benzoxonium chloride and lauramine oxide as culprit allergens in a popular antiseptic in Switzerland by Wüthrich, Héloïse, Yatim, Ahmad, Di Lucca, Julie, Walker, Anna, Ventejou, Sarah, Morren, Marie-Anne, Goossens, An, Dendooven, Ella, Aerts, Olivier, Gilliet, Michel, Seremet, Teofila

“…A popular antiseptic spray in Switzerland (Merfen spray), containing chlorhexidine digluconate, benzoxonium chloride and lauramine oxide, is frequently used to…”
Get full text

Baseline biomarkers correlated with outcome in advanced melanoma treated with pembrolizumab monotherapy by Awada, Gil, Schwarze, Julia Katharina, Gondry, Odrade, Jansen, Yanina, Ong, SuFey, Gorman, Kara M., Warren, Sarah, Kockx, Mark, Seremet, Teofila, Keyaerts, Marleen, Everaert, Hendrik, Neyns, Bart

“…Abstract only e22041 Background: Pembrolizumab (PEMBRO) improves survival in advanced melanoma (MEL). This research investigates baseline (BL) biomarkers that…”
Get full text

A Comprehensive Analysis of Baseline Clinical Characteristics and Biomarkers Associated with Outcome in Advanced Melanoma Patients Treated with Pembrolizumab by Awada, Gil, Jansen, Yanina, Schwarze, Julia Katharina, Tijtgat, Jens, Hellinckx, Lennert, Gondry, Odrade, Vermeulen, Sim, Warren, Sarah, Schats, Kelly, van Dam, Pieter-Jan, Kockx, Mark, Keyaerts, Marleen, Everaert, Hendrik, Seremet, Teofila, Rogiers, Anne, Neyns, Bart

“…Pembrolizumab improves the survival of patients with advanced melanoma. A comprehensive analysis of baseline variables that predict the benefit of…”
Get full text

Anaphylaxis-like reaction to anti-BRAF inhibitor dabrafenib confirmed by drug provocation test by Seremet, Teofila, Haccuria, Amaryllis, Lienard, Danielle, Del Marmol, Véronique, Neyns, Bart

“…The combination of BRAF and MEK inhibitors is a standard therapeutic option for patients with metastatic melanoma with BRAF-mutated tumors. This type of…”
Get full text